How EXO Biologics plans to revolutionize exosome therapy with €16m cash injection
EXO Biologics, a clinical-stage biotech specializing in exosome-based therapies, recently announced the successful raising of €16 million in Series A funding.
Archives for May 28, 2024
Oncology research booms: Global investigator sites double in just five years
Clinical development analytics company Phesi has released a new analysis of global oncology trial investigator sites ahead of attending ASCO 2024 – the American Society of Clinical Oncology’s annual meeting.
Could Innovent Biologics’ mazdutide be a game-changer in type 2 diabetes treatment?
Innovent Biologics has revealed encouraging phase 3 (DREAMS-2) findings for mazdutide, showcasing its superiority over dulaglutide in managing glycemic levels among patients with type 2 diabetes (T2D) in China.